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S An ll-year-old boy with terminal 
ummary hepatic failure due to Wilson's disease 
was treated 18 months ago with orthotopic liver 
transplantation. Postoperatively, there has been 
evidence of clearance of body copper stores but with-
out accumulation of copper in biopsy specimens of 
the transplanted liver after 6 and 17 months. Further 
follow-up will be necessary before deciding whether 
the disorder has been cured by liver replacement and 
in turn whether this constitutes proof that Wilson's 
disease is an inborn error of hepatic metabolism. 
The observations so far are consistent with these 
conclusions. 
Introduction 
D-PENICILLAMINE is recognised as the treatment of 
choice in Wilson's disease. 1- 3 However, even with 
therapy some patients are left with post-necrotic 
cirrhosis and portal hypertension,. In addition, a 
small group of patients has been labelled as having 
"acute Wilson's disease" 4-8_an entity which has 
the distinctive hepatic histopathological feature of 
Mallory bodies, and an extremely high mortality-rate 
despite treatment with specific copper-chelating 
agents. Moreover, even the more chronic form of 
Wilson's disease may lead to severe hepatic insuffi-
ciency, particularly in children, before the appearance 
of any diagnostic neurological or ocular signs. 7-8 
We report here a case of Wilson's disease which 
was treated successfully by total host hepatectomy 
and orthotopic homotransplantation of a cadaveric 
liver. There has been no clinical or biochemical 
evidence of recurrence of Wilson's disease in the one 
and a half years of postoperative follow-up. 
Case-report 
An ll-year-old boy was admitted on July 14, 1969, in 
hepatic pre-coma. He was said to have had a protuberant 
abdomen since birth. Although he had developed generalised 
pruritus at 8 months of age, the diagnosis of a liver disorder 
was not definitely established until admission to another 
hospital in April, 1966. At that time the cephalin floccu-
lation was 4+, bromsulphalein retention was 30% at 
45 minutes, and serum-alkaline-phosphatase was 16·4 
Bodansky units (normal less than 5). An open liver biopsy 
was reported as " post-necrotic cirrhosis". In April, 1969, 
he was admitted to a second hospital with obvious advanced 
liver disease. There were no Kayser-Fleischer rings on 
slit-lamp examination. A second liver biopsy again showed 
cirrhosis, with the additional finding of the alcoholic 
hyaline of Mallory. This biopsy was interpreted as being 
consistent with Wilson's disease. The diagnosis of Wilson's 
disease was supported by the eventual histopathological 
study of the excised liver by members of our staffs and 
several consulting pathologists, including Dr. Hans Popper 
(New York) and Prof. K. A. Porter (London). 
The patient was transferred to the University of Colorado 
Medical Center in hepatic pre-coma. He had anasarca and 
massive ascites. There were prominent venous collaterals 
on the abdomen, spider angiomas on the chest and upper 
extremities, and liver palms. Gynrecomastia was not present. 
He was somnolent, disoriented, and incontinent with fetor 
hepaticus. He had marked clonus and was hyper-refiexic, 
but the Babinski responses were equivocal. He had no 
evidence of asterixis. The serum-bilirubin was 20·6 mg. 
per 100 mI., the serum-alkaline-phosphatase 35 I.U. per litre 
(normal 57-258), S.G.O.T. 49 I.U. per litre (normal 3-27), 
S.G.P.T. 14I.U. per litre (normal 1-30), serum-total-protein 
4·5 g. per 100 mI., serum-albumin 1·5 g. per 100 ml., 
y-globulin 2·2 g. per 100 mI., prothrombin-time 31·5 
seconds (control 13 seconds) or 13%. The hrematocrit 
was 27%; white blood-cells 15,000 per c.mm.; platelets 
30,000 per c.mm. The blood-ammonia was 432 mg. nitro-
gen per 100 ml. and the electroencephalogram was markedly 
abnormal, showing diffuse slow waves, compatible with a 
metabolic encephalopathy. 
Within a few hours of his arrival the patient developed 
upper-gastrointestinal hremorrhage and became agonal. 
Although the preoperative diagnosis was Wilson's disease, 
no consideration was given to the possibility of n-penicilI-
amine treatment, since death was imminent. 
Transplantation 
When the abdomen had been entered through a bilateral 
subcostal incision, several litres of ascitic fluid were aspira-
ted. The liver was dark brown, firm, and the site df 
finely nodular cirrhosis. The organ was removed in its 
entirety and replaced 10 with an orthotopic hepatic homo-
graft from a cadaveric donor of approximately the same age 
as the recipient. The donor had no stigmata or family 
history suggestive of Wilson's disease and the serum copper 
and creruloplasmin were within normal limits. 
The excised native liver weighed 540 g., compared to a 
predicted 840 g. for a child of this age and weight. Biliary 
drainage was with cholecystoduodenostomy. The recipi-
ent's greatly enlarged spleen was also removed. Grossly 
and microscopically there were multiple splenic inf~rctsK 
Because of extensive venous collaterals, the operation was a 
difficult one, necessitating transfusion of 12 litres 
blood. 
Post-transplantation Course 
There was an immediate clearing of the sensorium, a fall 
in the serum-bilirubin and blood-ammonia levels, an 
increase in the total-serum-protein, and a reduction in the 
prothrombin-time. The patient was treated with a triple-
drug immunosuppressive regimen that included azathio-
prine, prednisone, and heterologous antilymphocyte 
globulin (A.L.G.).10 Two severe rejection episodes occurred 
--one after a few days and the other after 3 weeks. The 
most prominent biochemical findings at these times were 
changes suggestive of biliary-tract obstruction, with an 
extreme degree of hyperbilirubina:mia (maximum 43 mg. 
per 100 mI.), of which most was glucuronide, and raised 
alkaline phosphatase (maximum 990 I.U. per litre) (fig. 1). 
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With reversal of the second rejection episode, these and the 
other adverse findings of rejection receded completely. The 
patient has had essentially normal hepatic function since 
6 months post-transplantation (fig. 1). 
Open biopsies of the homograft, obtained after 6 and 
17 months, were studied for evidence of rejection by 
Prof. K. A. Porter, of St. Mary's Hospital and Medical 
School, London. The initial biopsy, apart from some cellular 
infiltration of the portal tracts and prominence of the 
Kupffer cells, was essentially normal. The second biopsy 
showed some excess reticulin and collagen in and around 
the portal tracts and also around some of the liver lobules. 
A few of the small hepatic-artery branches now showed 
some intimal thickening. 
The patient is receiving 37·5 mg. azathioprine and 
15 mg. of prednisone daily. He now has no demonstrable 
neurological impairment or evidence of Kayser-Fleischer 
rings on slit-lamp examination. No dietary limitations have 
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Fig. I-Course after liver replacement. 
A.L.G. =horse antilymphocyte globulin. 
been imposed, and D-penicillamine or potassium sulphide 
have never been administered except during the tests to 
be described below. 
Studies of Copper Metabolism 
The diagnosis of Wilson's disease was confirmed by 
determining the copper content of the frozen native liver. 
As measured in the Denver laboratory,ll the excised organ 
had 216 (Lg. copper per gramme wet weight. In the New 
York laboratory, 12 the copper per gramme dry weight was 
1313 fig. Except for Wilson's disease, hepatic copper 
values approaching these levels have been reported only in 
primary biliary cirrhosis or biliary atresia. 13 ,14 As controls 
in the Colorado laboratory, the copper concentration was 
determined in 11 livers that were affected by biliary atresia 
(2 examples), hepatoma (2 examples), chronic active 
hepatitis (5 examples), and cirrhosis (2 examples). The 
values averaged 17·4 (Lg. of copper per gramme wet liver 
(range 9-45), the highest content being in the liver of an 
ll-year-old girl with intrahepatic biliary atresia. 
During both the previous admissions to other hospitals, 
several other relevant studies were obtained. In April, 
1966, the 24-hour urinary copper excretion was 50 (Lg. on 
two occasions, a normal value in that laboratory. The 
serum-copper was 178 (Lg. per 100 mi. (normal stated to be 
80-280). In April, 1969, during the second admission to 
hospital elsewhere, serum-creruloplasmin was reported as 
26 mg. per 100 ml. (normal 20-40). Preoperative czrulo-
plasmin values in the Denver laboratories in three different 
preoperative specimens after freeze storage for 6 months 
were 26, 27, and 31 mg. per 100 ml., using an enzymatic 
assay." The concentration in the first sample was found 
to be 28 mg. per 100 ml. by Dr. George Cartwright, of the 
University of Utah, using a similar analytical method. 
However, in the New York laboratory, czruloplasmin 
concentration of this specimen was 15 mg. per 100 ml. by 
enzymatic assay 12 as well as with a calibrated immuno-
chemical method. IS 
Following liver transplantation, serial 24-hour urinary 
copper excretion was determined repeatedly. There was a 
massive cupriuresis which declined to normal (less than 
30 fig. per 24 hours) after several months (fig. 2). At the 
end of 7 months a 3-day course of D-peniciIlamine (1'5 g. 
per day) was given and there was a 20-fold increase in 
urine copper excretion, which then rapidly returned to 
normal. Copper excretion remained normal until 15 
months post-transplantation, at which time it became 
slightly elevated (fig. 2). During the 18 months of follow-
up, 15 serial serum-czruloplasmins varied from 29·5 to 
55 mg. per 100 ml. (normal 22-43) and coincidentally 
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Fig. 2-Urinary excretion of copper after orthotopic liver 
transplantation for Wilson's di.ease. 
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FINDINGS IN PATIENT'S RELATIVES 
24 hr. 
Case CR:ruJoplasmin Serum-copper urine- lieu: ratio (mg./IOO mi.)' (lLg./lOO m1.)t copper ~hrK/1-OhrK§ 
(lLg.); 
Father 31·5 135 17 1'606 
Mother .. 58·9 183 6 1,354 
Sibling 1 24·5 81 4 0·858 
Sibling 2 29·0 113 5 1'104 
Sibling 3 67'9 198 5 2'030 
• Normal = 22-43. t Normal ~TM-11UK t Normal = < 30. 
§ Heterozygotes ~ < 0·599. 
measured serum-coppers ranged from 8U to 171 Ilg. per 
100 m!. (normal 70-118). 
The homograft biopsies obtained at 6 months and 17 
months after transplantation contained 15 and 13·6 (Lg. 
copper per gramme wet weight in the Denver laboratory 
(normal less than 20). The dry weight per gramme liver in 
the New York laboratories at 6 and 17 months was 54 and 
21·3 (Lg. 
As controls, cases were studied in which orthotopic 
hepatic transplantation was carried out for indications 
other than Wilson's disease. 24-hour urine-copper excre-
tion was estimated in three patients 40-665 days after liver 
replacement for biliary atresia; this ranged from 18 to 
26 (Lg. per 24 hours. In addition, copper was measured in 
twelve livers that had been transplanted 35-400 days pre-
viously to patients with biliary atresia or hepatoma. The 
grafts contained an average of 10·5 (Lg. copper per gramme 
wet weight liver tissue (range 7-19). 
Genetic Studies 
Both parents and all three siblings of the patient had 
24-hour urinary copper excretion and serum copper and 
czruloplasmin estimations. In addition, these family 
members had 6'eu-incorporation studies performed 11 (see 
table). There was no clear evidence that either parent or 
any of the other children were heterozygous. The mother 
was not taking contraceptive pills at the time of testing, nor 
has she ever done so in the past. 
Renal Function 
Before operation the blood-urea~nitrogen was 17 mg. per 
100 m!. and the serum-creatinine 1·0 mg. per 100 m!. 
Unfortunately, no other evaluation of renal function could 
be obtained. Afterwards, serial phosphorus and creatinine 
clearances were performed. Aminoacids were measured by 
ion-exchange chromatography on a 'Beckman-Spinco' 
aminoacid analyser and phenylalanine, tyrosine, alanine, 
glycine, glutamine, and serine clearances were determined. 11 
The measures were within normal limits at all times post-
transplantation, thereby ruling out the possibility that the 
renal injury sometimes associated with Wilson's disease 17,18 
had developed. 
Discussion 
The characteristic findings in Wilson's disease ",11, I. 
can include a low serum-creruloplasmin, an increased 
urinary excretion of copper, an elevation of non-
creruloplasmin copper in the serum, Kayser-Fleischer 
rings, and an elevated copper content of the liver and 
other organs. Any or all of these diagnostic criteria, 
except the last one, may be absent 8,9,10,10; and this 
may lead to the tragedy of not providing treatment 
with the cheiating agent, penicillamine. Moreover, 
since creruiopiasmin levels are depressed in only about 
10% of heterozygous carriers of the abnormal gene, 
and the 64Cu-incorporation test is of only fair reli-
ability, the findings in the siblings and parents of our 
patient cannot be regarded as proof that some of them 
do not possess a single" Wilson's disease gene". 
In our patient, Wilson's disease was suspected 
intermittently in the 3 years preceding transplantation, 
but the results of the biochemical tests of serum and/ 
or urine were either normal or equivocal. For example, 
all the preoperative creruloplasmin determinations 
were within normal limits except one result from the 
New York laboratories. These generally negative 
findings plus the absence of the Kayser-Fleischer 
rings delayed recognition of the disease until there 
was no hope of conservative medicinal treatment. 
Nevertheless, the firm diagnosis of Wilson's disease 
was ultimately established from the high copper 
concentration in the native liver as well as from the 
presence of Mallory bodies 'in this specimen. The 
first of these abnormalities can be found in primary 
biliary cirrhosis or atresia, 13,14 and the second may 
be present in alcoholic cirrhosis 21 or Indian child-
hood cirrhosis, 2 2 but obviously these diagnoses did 
not pertain to this ll-year-old white American boy. 
Despite the absence of several of the common 
criteria for the diagnosis of Wilson's disease, evidence 
of extensive copper deposition in extrahepatic tissues 
was provided indirectly by the massive cupriuresis 
which followed operation and which continued for 
several months before the urinary copper level 
returned to normal. Even after 7 months, the mag-
nitude of urinary copper excretion in response to a 
3-day penicillamine course was somewhat greater than 
is usually observed in normal people. I, 23 At all times 
in the past year, urine excretion of copper has been 
slightly elevated, either at high normal or above. 
It has been suggested by Walshe 20 and by Sternlieb 
and Scheinberg 19 and others that in Wilson's disease 
the primary defect is hepatic. This hypothesis is 
based upon the fact that in all clinical permutations 
of the disease the highest concentrations of copper 
are in the liver. The extrahepatic organ systems are 
presumably not affected until the buffering capacity 
of the liver for copper is exceeded. Thereafter toxic 
levels presumably develop in other parts of the body. 
If the essential defect in Wilson's disease were 
hepatic, provision of a new liver would be expected 
to be curative, since liver homografts and the pro-
teins they synthesise retain their donor specificity 
in the new host for a long time and probably per-
Printed in 
Great Britain 
4 
.-----.. _._---_._-
manently.IO, 2', 27 Consequently, the studies in our 
case are consistent with the hypothesis that Wilson's 
disease is a liver-based inborn error of metabolism, 
although they do not prove it. In the 18 months 
since the liver was transplanted the total body-copper 
has declined steadily, while the copper concentration 
in the new liver has .remained normal. In so far as can 
be determined within the limits of the follow-up, 
this patient now has no clinical or biochemical evidence 
of Wilson's disease. 
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